Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Virus-specific mRNA capping enzyme encoded by hepatitis E virus.

J Magden1, N Takeda, T Li

  • 1Program in Cellular Biotechnology, Institute of Biotechnology, Viikki Biocenter, Viikinkaari 9, 00014 University of Helsinki, Finland.

Journal of Virology
|June 20, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The anti SARS-CoV-2 activity of nanofibrous filter materials activated with metal clusters.

Atmospheric Environment: X·2023
Same author

Synthesis of novel acyclic nucleoside analogues with anti-retroviral activity.

Nucleosides, nucleotides & nucleic acids·2010
Same author

Biological, serological, and molecular differences among isolates of potato a potyvirus.

Phytopathology·2008
Same author

Semliki Forest virus strongly reduces mosquito host defence signaling.

Insect molecular biology·2008
Same author

Viral RNA replication in association with cellular membranes.

Current topics in microbiology and immunology·2004
Same author

Inhibition of the membrane fusion machinery prevents exit from the TGN and proteolytic processing by furin.

FEBS letters·2001

Hepatitis E virus (HEV) P110 protein acts as both a methyltransferase and guanylyltransferase, crucial for viral replication. These enzymatic activities, essential for HEV, present potential targets for developing new antiviral drugs against this waterborne hepatitis agent.

Area of Science:

  • Virology
  • Molecular Biology
  • Biochemistry

Background:

  • Hepatitis E virus (HEV) is a significant cause of waterborne hepatitis.
  • HEV is a positive-strand RNA virus.
  • Understanding HEV's replication mechanisms is key to developing antiviral strategies.

Purpose of the Study:

  • To characterize the enzymatic activities of the HEV nonstructural open reading frame 1 protein (P110).
  • To investigate the potential of these enzymatic activities as targets for antiviral drug development.

Main Methods:

  • Expressed HEV nonstructural open reading frame 1 cDNA in insect cells to produce P110.
  • Assessed P110's methyltransferase and guanylyltransferase activities using radiolabeled substrates.
  • Tested the inhibitory effects of cap analogs on P110's enzymatic reactions.

Related Experiment Videos

Main Results:

  • HEV P110 protein exhibits both methyltransferase and guanylyltransferase activities, essential for capping viral RNA.
  • P110 catalyzes the transfer of a methyl group from S-adenosylmethionine to GTP/GDP and forms a covalent complex with GTP.
  • Cap analogs inhibited the methyltransferase activity, suggesting a potential therapeutic avenue.

Conclusions:

  • The methyltransferase and guanylyltransferase activities of HEV P110 are virus-specific and essential for viral replication.
  • These enzymatic functions represent promising targets for the development of novel antiviral drugs against Hepatitis E.
  • Similarities between HEV P110 and enzymes from plant viruses suggest a common evolutionary origin.